StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

SLDBBullishAnalyst Target Updateanalyst
High materiality7/10

Solid Biosciences assumed with a Buy at Truist

Aug 21, 2026, 10:02 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

positive

AI summary

What happened, with direct paths to the underlying reporting

Truist Financial initiated coverage on SLDB with a Buy rating and a $20 target. Current price shown as $9.10. Price has advanced 4.29 since the signal. Analyst: Danielle Brill.

  • Truist starts Buy on SLDB with a $20 PT; price $9.10; up 4.29 since signal.

Key facts

  1. 01

    Target: $20

  2. 02

    Posted price: $9.1

  3. 03

    Analyst firm: Truist Financial

  4. 04

    Analyst: Danielle Brill

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.